HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Epidemic typhus in a prison in Burundi.

AbstractThe International Committee of the Red Cross investigated an outbreak of fever of unknown origin in Ngozi prison, Burundi, which resulted in a crude mortality rate of 2.61% in January 1996. A definite diagnosis of epidemic typhus caused by Rickettsia prowazekii was established by enzyme-linked immunosorbent assay using specific antigens. Control measures included complete cleansing of the prison with cyfluthrine, shaving and dusting all prisoners with permethrin 0.5% dusting powder, and replacement of all mattresses and clothes. All prisoners and guards received a single dose of doxycyline (100 mg) simultaneously. The crude mortality rate dropped abruptly to 1.27% in February 1996 and remained at or below 0.5% from March onwards. Health authorities and medical agencies working in Burundi need to consider epidemic typhus in the differential diagnosis of fever of unknown origin in order to be able to take appropriate control measures in time.
AuthorsG Bise, R Coninx (Affiliation: International Committee of the Red Cross, Geneva, Switzerland.)
JournalTransactions of the Royal Society of Tropical Medicine and Hygiene (Trans R Soc Trop Med Hyg) 1997 Mar-Apr Vol. 91 Issue 2 Pg. 133-4 ISSN: 0035-9203 [Print] ENGLAND
PMID9196749 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Doxycycline
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Burundi (epidemiology)
  • Disease Outbreaks
  • Doxycycline (therapeutic use)
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Prisons (statistics & numerical data)
  • Rickettsia prowazekii (isolation & purification)
  • Serologic Tests
  • Typhus, Epidemic Louse-Borne (drug therapy, epidemiology, mortality, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD